1. Home
  2. CHCO vs EVO Comparison

CHCO vs EVO Comparison

Compare CHCO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCO
  • EVO
  • Stock Information
  • Founded
  • CHCO 1957
  • EVO 1993
  • Country
  • CHCO United States
  • EVO Germany
  • Employees
  • CHCO N/A
  • EVO N/A
  • Industry
  • CHCO Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHCO Finance
  • EVO Health Care
  • Exchange
  • CHCO Nasdaq
  • EVO Nasdaq
  • Market Cap
  • CHCO 1.9B
  • EVO 1.6B
  • IPO Year
  • CHCO N/A
  • EVO 2021
  • Fundamental
  • Price
  • CHCO $127.44
  • EVO $4.78
  • Analyst Decision
  • CHCO Hold
  • EVO Buy
  • Analyst Count
  • CHCO 4
  • EVO 2
  • Target Price
  • CHCO $117.25
  • EVO $5.90
  • AVG Volume (30 Days)
  • CHCO 50.8K
  • EVO 152.3K
  • Earning Date
  • CHCO 01-22-2025
  • EVO 11-06-2024
  • Dividend Yield
  • CHCO 2.44%
  • EVO N/A
  • EPS Growth
  • CHCO N/A
  • EVO N/A
  • EPS
  • CHCO 7.80
  • EVO N/A
  • Revenue
  • CHCO $289,546,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • CHCO N/A
  • EVO $4.56
  • Revenue Next Year
  • CHCO $0.35
  • EVO $13.44
  • P/E Ratio
  • CHCO $16.36
  • EVO N/A
  • Revenue Growth
  • CHCO 0.71
  • EVO N/A
  • 52 Week Low
  • CHCO $97.50
  • EVO $2.85
  • 52 Week High
  • CHCO $137.28
  • EVO $12.00
  • Technical
  • Relative Strength Index (RSI)
  • CHCO 47.10
  • EVO 54.36
  • Support Level
  • CHCO $127.06
  • EVO $4.39
  • Resistance Level
  • CHCO $131.26
  • EVO $4.76
  • Average True Range (ATR)
  • CHCO 2.71
  • EVO 0.13
  • MACD
  • CHCO -0.72
  • EVO -0.05
  • Stochastic Oscillator
  • CHCO 17.21
  • EVO 78.00

About CHCO City Holding Company

City Holding Co is a financial holding company. It provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, saving accounts, credit card and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance, technology products, and others. These products and services are provided to commercial banking, consumer banking, mortgage banking, wealth management, and trust services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: